What is it about?
Retrovirus Epidemiology Donor Study (REDS) is the name of a multicenter transfusion safety research program funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) in the United States of America. Actually, Brazil participates in this program as an international partner. We reviewed manuscripts published during this program in Brazil.
Featured Image
Why is it important?
Studies about blood donation, Chagas Disease and HIV, for instance, can help to understand these issues not just in Brazil but also in other developed and developing countries.
Perspectives
This program has been remarkably successful in conducting important research to advance blood safety and availability in Brazil. Additionally, Brazilian participating centers have further developed strong partnerships with researchers from the US and other countries, and are developing the expertise in Brazil necessary to the establishment and continuation of a research network that can serve as an example to other countries.
Dr Cesar de Almeida-Neto
Faculty of Medicine, University of São Paulo
Read the Original
This page is a summary of: Contribution of the Retrovirus Epidemiology Donor Study (REDS) to research on blood transfusion safety in Brazil, Revista Brasileira de Hematologia e Hemoterapia, March 2014, Elsevier,
DOI: 10.5581/1516-8484.20140033.
You can read the full text:
Contributors
The following have contributed to this page
